Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119042) titled 'Low-Dose Rituximab and a Rapid Steroid-Tapering Regimen in Adults with Minimal Change Disease' on Feb. 14.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: The First Affiliated Hospital of Fujian Medical University

Condition: Minimal Change Disease

Intervention: Control Group:Conventional corticosteroid regimen

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-06-02

Target Sample Size: Control Group:62;Intervention Group:62;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=294678

Publishe...